Prevalence of alternative lengthening of telomeres in pediatric sarcomas determined by the telomeric DNA C-circle assay
- Trevor A Burrow 1,2, Balakrishna Koneru 1, Shawn J Macha 1,3, Wenyue Sun 4, Frederic G Barr 4, Timothy J Triche 5, C Patrick Reynolds 1,2,3
- Trevor A Burrow 1,2, Balakrishna Koneru 1, Shawn J Macha 1,3
- 1Department of Pediatrics, Texas Tech University Health Sciences Center School of Medicine Cancer Center, Lubbock, TX, United States.
- 2Department of Translational Neuroscience and Pharmacology, Texas Tech University Health Sciences Center, Lubbock, TX, United States.
- 3Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center Graduate School of Biomedical Sciences, Lubbock, TX, United States.
- 4Laboratory of Pathology, National Cancer Institute, Bethesda, MD, United States.
- 5Children's Hospital Los Angles, Department of Pathology and Laboratory Medicine, Keck School of Medicine of University of Southern California, Los Angeles, CA, United States.
- 0Department of Pediatrics, Texas Tech University Health Sciences Center School of Medicine Cancer Center, Lubbock, TX, United States.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Alternative lengthening of telomeres (ALT) was detected in 2.7% of rhabdomyosarcomas and 71% of osteosarcomas using the C-circle assay. This assay is a sensitive biomarker for ALT cancers, including sarcomas.
Area Of Science
- Oncology
- Molecular Biology
- Genetics
Background
- Alternative lengthening of telomeres (ALT) is a telomere maintenance mechanism observed in various cancers.
- ALT cancers exhibit distinct patterns of therapy resistance and sensitivity.
- Telomeric DNA C-circles are specific biomarkers for ALT cancers.
Purpose Of The Study
- To determine the frequency of ALT in pediatric sarcomas, specifically Ewing's family sarcoma (EFS), rhabdomyosarcoma (RMS), and osteosarcoma (OS).
- To evaluate the utility of the C-circle assay (CCA) for detecting ALT in these sarcoma subtypes.
Main Methods
- DNA was extracted from fresh frozen primary tumor samples of EFS, RMS, and OS.
- C-circles were enriched using isothermal rolling cycle amplification.
- Real-time PCR was employed to detect and quantify C-circles, utilizing established cutoffs.
Main Results
- Out of 94 EFS samples, 0 were C-circle positive (0% ALT).
- Out of 187 RMS samples, 5 were C-circle positive (2.7% ALT).
- Out of 87 OS samples, 62 were C-circle positive (71% ALT).
Conclusions
- The C-circle assay (CCA) identified ALT in 2.7% of RMS and 71% of OS, with no ALT detected in EFS.
- CCA is a robust and sensitive method for identifying ALT in sarcomas.
- CCA holds potential as a companion diagnostic for targeted ALT therapeutics.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
02:15
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
02:41
In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...

